 This Randomized Controlled Trial RCT seeks to test the efficacy and dose responsiveness of a manualized family therapy intervention called Family Focused Grief Therapy FFGT, which is delivered to families of patients with advanced disease and continued into bereavement. Randomization is to three arms: 6 sessions of FFGT, 10 sessions of FFGT, or standard care. The study also explores the potential mediators of effective outcome, empowering further refinement of the intervention, and undertakes an analysis of health-related costs of bereavement care. It is a multi-site study involving Memorial Hospital for Cancer and Allied Diseases a comprehensive cancer center, Calvary Hospital a dedicated palliative care hospital with home hospice care programand Beth Israel a medical center with a dedicated pain and palliative care department. Consenting families will be assessed at baseline through completion of questionnaires that appraise each individuals psychosocial well-being and perception of their familys functioning. Therapy will be delivered by family therapists social workers, psychologists, and psychiatrists, who will attend regular supervision sessions to sustain fidelity of the model of intervention. Follow-up of family members for psychosocial well-being, perceptions of family functioning, and costs of heath-related care will occur at 3, 6, 9, 13 months after the patients death or completion of therapy sessions. 